Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.45 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20601941 | 0.91 | CYP4F2 (0.49) | CYP4F2CYP4A11LMNANPSR1 | |
| SCHEMBL20617478 | 0.82 | CYP4F2 (0.50) | CYP4F2CYP4A11LMNANPSR1 | |
| SCHEMBL21963873 | 0.81 | CYP4F2 (0.40) | CYP4F2CYP4A11LMNANPSR1 | |
| SCHEMBL20601947 | 0.81 | CYP4F2 (0.49) | CYP4F2CYP4A11LMNANPSR1 | |
| SCHEMBL16142018 | 0.76 | CYP4F2 (0.47) | CYP4F2CYP4A11NPSR1 | |
| SCHEMBL31369221 | 0.75 | CYP4F2 (0.36) | CYP4F2CYP4A11LMNANPSR1 | |
| SCHEMBL4763096 | 0.74 | CYP4F2 (0.41) | CYP4F2CYP4A11LMNA | |
| SCHEMBL28419664 | 0.74 | CYP4F2 (0.41) | CYP4F2CYP4A11LMNANPSR1 | |
| SCHEMBL2824808 | 0.74 | CYP4F2 (0.41) | CYP4F2CYP4A11NPSR1 | |
| SCHEMBL18208201 | 0.74 | CYP4F2 (0.45) | CYP4F2CYP4A11NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014160649-A1 | HYDROXAMIC ACID DERIVATIVES AS LPXC INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS | NOVARTIS AG (CH) | 2014-10-02 | — | — | WO | disclosed |